These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 8890396)
1. Pathogenesis and treatment of calcium stones. Parks JH; Coe FL Semin Nephrol; 1996 Sep; 16(5):398-411. PubMed ID: 8890396 [TBL] [Abstract][Full Text] [Related]
2. Pathophysiology and therapy of hypercalciuria in patients who form recurrent stones. Ritz E; Schmidt-Gayk H; Möhring K Eur Urol; 1975; 1(3):131-3. PubMed ID: 183957 [TBL] [Abstract][Full Text] [Related]
3. [Nephrolithiasis in hypercalciuria and hyperparathyroidism]. Rapado A; de la Calle H; Castrillo JM; Mancha A; Traba ML; Delatte LC MMW Munch Med Wochenschr; 1976 Jun; 118(25):799-810. PubMed ID: 819807 [TBL] [Abstract][Full Text] [Related]
4. [Experimental and clinical studies on calcium lithiasis. II. Prevention of recurrent calcium stones with thiazides and allopurinol]. Okada Y; Nonomura M; Takeuchi H; Kawamura J; Yoshida O Hinyokika Kiyo; 1986 Sep; 32(9):1247-57. PubMed ID: 3812144 [TBL] [Abstract][Full Text] [Related]
5. Etiopathogenesis, clinical manifestations, and management of canine calcium oxalate urolithiasis. Osborne CA; Poffenbarger EM; Klausner JS; Johnston SD; Griffith DP Vet Clin North Am Small Anim Pract; 1986 Jan; 16(1):133-70. PubMed ID: 3518199 [TBL] [Abstract][Full Text] [Related]
6. [Conservative therapy of phosphate calculi]. Lycklama à Nijeholt AA; Jonas U Urologe A; 1984 Mar; 23(2):91-4. PubMed ID: 6539026 [TBL] [Abstract][Full Text] [Related]
7. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions. Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288 [TBL] [Abstract][Full Text] [Related]
8. [Hyperparathyroidism in urology today. New etiopathogenetic, diagnostic and therapeutic acquisitions]. Giuliani L; Carmignani G; Belgrano E; Puppo P; Cichero A; Repetto U Minerva Urol; 1980; 32(3):133-52. PubMed ID: 6776394 [No Abstract] [Full Text] [Related]
12. The benefits of evaluation of the patient with recurrent or multiple calcium stones. Peterson LJ; Hruska KA J Urol; 1979 Jun; 121(6):766-8. PubMed ID: 458948 [TBL] [Abstract][Full Text] [Related]
13. Urinary risk factors for recurrent calcium stone formation in Thai stone formers. Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123 [TBL] [Abstract][Full Text] [Related]
14. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats. Bushinsky DA; Asplin JR J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic treatment of renal calcium stones. Experiences with dietary advice, cellulose, phosphate and thiazides. Ljunghall S; Backman U; Danielson BG; Fellström B; Johansson G; Wikström B Scand J Urol Nephrol Suppl; 1980; 53():239-52. PubMed ID: 6938001 [No Abstract] [Full Text] [Related]
16. [Hypercalciuria; current diagnostic and therapeutic considerations]. Fuss M; Verbeelen D; Geurts J; Fontinoy N Brux Med; 1977 Feb; 57(2):59-64. PubMed ID: 851899 [No Abstract] [Full Text] [Related]
18. Kidney stones: current issues in diagnosis and therapy. Brown DC Postgrad Med; 1982 Dec; 72(6):124-33. PubMed ID: 6755415 [TBL] [Abstract][Full Text] [Related]
19. Long-term treatment of calcium nephrolithiasis with potassium citrate. Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044 [TBL] [Abstract][Full Text] [Related]